Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ: IMRN )

1.780 +0.019 (+1.07%)
Streaming Delayed Price Updated: 1:04 PM EDT, Mar 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
Immuron Director Resignation
From Immuron Limited
Via GlobeNewswire
Immuron to host Live Virtual Event
From Immuron Limited
Via GlobeNewswire
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. 
Via Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. 
Via Benzinga
Immuron Travelan® sales continued strong growth
From Immuron Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart... 
Via Benzinga
Exposures Product Safety
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2024 strategic layout with plans to enter the real estate stock asset... 
Via Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Porch Group Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Porch Group, Inc. (NASDAQ: PRCH) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning! 
Via InvestorPlace
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
From Immuron Limited
Via GlobeNewswire
Immuron Presentation Australian Biologics Festival 2024
From Immuron Limited
Via GlobeNewswire
Immuron achieves record Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Immuron achieves record half yearly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron Clinical Trials Update
From Immuron Limited
Via GlobeNewswire
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Immuron CEO Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Immuron CEO Steven Lydeamore presented at AusBioInvest
From Immuron Limited
Via GlobeNewswire
Immuron Announces Travelan® Clinical Study Cohort 2 commences
From Immuron Limited
Via GlobeNewswire
Immuron achieves record quarterly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron hails record monthly sales of Travelan
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan®.... 
Via TheNewswire.com
Immuron hails record monthly sales of Travelan
--News Direct-- 
Via News Direct
Immuron achieves record monthly Travelan® sales
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.